These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30821293)

  • 1. [The COMMANDER-HF trial].
    Dinatolo E; Metra M
    G Ital Cardiol (Rome); 2019 Mar; 20(3):123-125. PubMed ID: 30821293
    [No Abstract]   [Full Text] [Related]  

  • 2. Should we use anticoagulation for patients with chronic heart failure?
    Freudenberger RS; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):580-1. PubMed ID: 17063158
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of venous thromboembolism among hospitalized medical patients.
    Goldhaber SZ; Turpie AG
    Circulation; 2005 Jan; 111(1):e1-3. PubMed ID: 15630031
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic therapy in heart failure.
    Verheugt FW
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):277-8. PubMed ID: 16716103
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice.
    Siliste RN; Antohi EL; Pepoyan S; Nakou E; Vardas P
    Eur J Heart Fail; 2018 Jun; 20(6):978-988. PubMed ID: 29504188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant and antiplatelet therapy in heart failure.
    Cleland JG
    Curr Opin Cardiol; 1997 May; 12(3):276-87. PubMed ID: 9243085
    [No Abstract]   [Full Text] [Related]  

  • 8. [For which patients with cardiac decompensation is prevention of thromboembolism advisable?].
    G Ital Cardiol; 1994 Oct; 24(10):1341-6. PubMed ID: 7835568
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulation in patients with heart failure and normal sinus rhythm.
    Ripley TL; Nutescu E
    Am J Health Syst Pharm; 2009 Jan; 66(2):134-41. PubMed ID: 19139477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the appropriate approach to prevention of thromboembolism in heart failure?
    Freudenberger RS; Schumaecker MM; Homma S
    Thromb Haemost; 2010 Mar; 103(3):489-95. PubMed ID: 20024492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy for heart failure in sinus rhythm.
    Subramaniam V; Davis RC; Shantsila E; Lip GY
    Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives.
    Gurbel PA; Tantry US
    JACC Heart Fail; 2014 Feb; 2(1):1-14. PubMed ID: 24622113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation Therapy and NOACs in Heart Failure.
    Thomas I; EncisoSilva J; Schlueter M; Greenberg B
    Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation in atrial fibrillation with heart failure.
    Zhao L; Wang WYS; Yang X
    Heart Fail Rev; 2018 Jul; 23(4):563-571. PubMed ID: 29569146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis and treatment of venous thromboembolism in patients with cancer.
    Ageno W; Squizzato A
    Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).
    Lee TC; Qian M; Lip GYH; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S;
    Am J Cardiol; 2018 Sep; 122(5):821-827. PubMed ID: 30037426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulation in chronic heart failure and left ventricular dysfunction].
    Wichter T; Breithardt G
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2145-8. PubMed ID: 12397561
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-vitamin K antagonist oral anticoagulants and heart failure.
    Isnard R; Bauer F; Cohen-Solal A; Damy T; Donal E; Galinier M; Hagège A; Jourdain P; Leclercq C; Sabatier R; Trochu JN; Cohen A
    Arch Cardiovasc Dis; 2016 Nov; 109(11):641-650. PubMed ID: 27836786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of anticoagulants in the treatment of cardiac insufficiency in patients with rheumatic defects of the heart].
    Kushelevskiĭ BP; Rozhdestvenskaia ED
    Sov Med; 1967 Jul; 30(7):28-32. PubMed ID: 5607868
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure.
    Garg RK; Gheorghiade M; Jafri SM
    Prog Cardiovasc Dis; 1998; 41(3):225-36. PubMed ID: 9872608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.